Sanecum Group, a portfolio company of Adiuva Capital, has received an additional 75 million euros in acquisition facilities from Deutsche Bank Direct Lending to continue its successful growth strategy. The additional funds will enable Sanecum to further invest in outpatient healthcare facilities and to establish new medical partnerships.

Founded in 2019, Sanecum is one of Germany’s fastest-growing healthcare companies for outpatient medical care in the fields of nephrology, cardiology, oncology and related diagnostics, in particular laboratory medicine and imaging. Around 300 physicians provide patient care in six regional clusters, covering eight federal states. The group’s success is based on the high quality of its medical services and its partnership-based cooperation with physicians. “With the expansion of our financing partners, we look forward to gaining further practices for our network and providing even better care for our patients,” says Managing Director Ulf Völkel, who founded Sanecum together with Dr. Susanne Hoischen.

Sanecum received advise from Rothschild and Baker McKenzie regarding the implementation of the new acquisition facility. Deutsche Bank was supported by a team from the law firm Ashurt.